Ambrx Biopharma Inc Asset Turnover Ratio (AMAM), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ambrx Biopharma Inc   (NASDAQ: AMAM)
 

Ambrx Biopharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the third quarter 2023, Ambrx Biopharma Inc 's asset turnover ratio sequentially decreased to 0.05 in the third quarter (Sep 30 2023), this is lower than usual.

Within sector 2 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2023 compared to the preceding quarter from 283 to 294.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMAM Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change 94.24 % 32.2 % -25.15 % -65.63 % -40.52 %
Y / Y Revenue Change -96.68 % -13.55 % -98.51 % -0.71 % -
Asset Turnover Ratio (TTM) 0.05 0.06 0.07 0.08 0.06
AMAM's Total Ranking # 294 # 283 # 0 # 0 #
Seq. Asset Change 7.02 % 44.24 % 120.55 % -42.94 % -27.17 %
Seq. Revenue Change -95.28 % 4579.17 % -99.68 % 363.49 % 22.94 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 27
Overall Market # 294

Asset Turnover Ratio Statistics
High Average Low
53.68 32.04 6.02
(Sep 30 2023)   (Dec 31 2021)




AMAM Company Profile • Back to AMAM Efficiency Comparisons • Compare AMAM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Abeona Therapeutics Inc   0.09 $ 5.301  Millions$ 59.299  Millions
Intelgenx Technologies Corp   0.09 $ 0.786  Millions$ 8.867  Millions
Innovative Eyewear Inc   0.09 $ 0.604  Millions$ 6.815  Millions
Aditxt Inc   0.09 $ 0.749  Millions$ 8.472  Millions
Biocardia Inc   0.08 $ 0.570  Millions$ 6.764  Millions
Kymera Therapeutics Inc   0.08 $ 46.846  Millions$ 587.841  Millions
Zomedica Corp   0.08 $ 22.049  Millions$ 277.260  Millions
Imagenebio Inc   0.08 $ 13.952  Millions$ 177.940  Millions
Lineage Cell Therapeutics Inc   0.08 $ 8.772  Millions$ 113.678  Millions
Soligenix inc   0.08 $ 0.961  Millions$ 12.628  Millions
Dermtech Inc   0.08 $ 12.651  Millions$ 168.541  Millions
Mountain Crest Acquisition Corp V  0.07 $ 0.958  Millions$ 12.814  Millions
Delcath Systems Inc   0.07 $ 2.164  Millions$ 29.272  Millions
Hyperfine Inc   0.07 $ 8.627  Millions$ 117.956  Millions
Avalo Therapeutics Inc   0.07 $ 2.250  Millions$ 30.777  Millions
Femasys Inc   0.07 $ 1.093  Millions$ 14.983  Millions
Recursion Pharmaceuticals Inc   0.07 $ 47.360  Millions$ 656.545  Millions
4d Molecular Therapeutics Inc   0.07 $ 21.989  Millions$ 304.996  Millions
Igc Pharma Inc   0.07 $ 1.343  Millions$ 19.048  Millions
Hcw Biologics Inc   0.07 $ 2.859  Millions$ 41.361  Millions
Tscan Therapeutics Inc   0.07 $ 16.933  Millions$ 245.243  Millions
Vbi Vaccines Inc  0.07 $ 8.122  Millions$ 118.163  Millions
Northwest Biotherapeutics Inc  0.07 $ 2.084  Millions$ 31.031  Millions
Abvc Biopharma Inc   0.06 $ 0.739  Millions$ 11.626  Millions
Solana Company  0.06 $ 0.792  Millions$ 12.662  Millions
Beam Therapeutics Inc   0.06 $ 81.554  Millions$ 1,329.622  Millions
Lyell Immunopharma Inc   0.06 $ 48.503  Millions$ 862.089  Millions
Cervomed Inc   0.05 $ 1.526  Millions$ 28.712  Millions
C4 Therapeutics Inc   0.05 $ 20.349  Millions$ 383.724  Millions
Tff Pharmaceuticals Inc  0.05 $ 0.932  Millions$ 17.697  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.